文献速递肝病

线粒体功能障碍调控慢加急性肝衰竭患者白细胞的免疫代谢

Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure.
PubMed 文献 · J Hepatol · 2021-08-25

该研究纳入108例无ACLF和128例伴ACLF的失代偿期肝硬化患者及41名健康对照,通过电镜、代谢通量分析、Luminex和LC-MS/MS检测白细胞线粒体形态与代谢通路。发现晚期肝硬化患者白细胞线粒体超微结构异常,ACLF患者TCA循环在异柠檬酸脱氢酶和琥珀酸脱氢酶水平出现断点,由谷氨酰胺分解和核苷代谢的补缺反应代偿。FGF21和C6:0-、C8:0-肉碱可预测死亡率,GDF15与白细胞活化基因特征强相关。

要点

  • 晚期肝硬化患者白细胞线粒体出现嵴稀疏和肿胀,数量增多但体积减小。
  • ACLF患者TCA循环在异柠檬酸脱氢酶和琥珀酸脱氢酶水平存在断点。
  • FGF21和C6:0-、C8:0-肉碱可预测死亡率,GDF15与白细胞活化相关。

核心结论

  • 细胞、细胞器和生化层面的证据表明,严重线粒体功能障碍调控失代偿期肝硬化和ACLF患者白细胞的免疫代谢。

研究设计与样本

  • 研究纳入失代偿期肝硬化患者(108例无ACLF、128例伴ACLF)和41名健康对照。
  • 采用透射电镜观察白细胞线粒体超微结构,通过多种底物评估NADH/FADH2产生以测定胞质和线粒体代谢通量。
  • 血浆GDF15和FGF21用Luminex检测,酰基肉碱用LC-MS/MS检测,基因表达用RNA测序和PCR葡萄糖代谢阵列分析。

主要发现

  • 晚期肝硬化患者白细胞线粒体超微结构表现为嵴稀疏和肿胀,每个白细胞的线粒体数量增多但体积减小。
  • FGF21和C6:0-、C8:0-肉碱可预测死亡率,GDF15与白细胞活化相关基因集特征强相关。
  • 代谢通量分析显示单核白细胞能量产生增加,优先涉及线粒体外通路,糖酵解和戊糖磷酸途径酶基因表达上调支持这一发现。
  • ACLF患者线粒体功能分析发现TCA循环在异柠檬酸脱氢酶和琥珀酸脱氢酶水平存在断点,由涉及谷氨酰胺分解和核苷代谢的补缺反应桥接。

临床怎么用

  • FGF21和C6:0-、C8:0-肉碱可作为预测失代偿期肝硬化患者死亡率的候选生物标志物。
  • GDF15与白细胞活化基因特征相关,可能反映ACLF中的免疫代谢状态。
  • 线粒体功能障碍是晚期肝病的标志,靶向免疫代谢可能为ACLF提供治疗思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with acute-on-chronic liver failure (ACLF) present a systemic hyperinflammatory response associated with increased circulating levels of small-molecule metabolites. To investigate whether these alterations reflect inadequate cell energy output, we assessed mitochondrial morphology and central metabolic pathways with emphasis on the tricarboxylic acid (TCA) cycle in peripheral leukocytes from patients with acutely decompensated (AD) cirrhosis, with and without ACLF. METHODS: The study included samples from patients with AD cirrhosis (108 without and 128 with ACLF) and 41 healthy individuals. Leukocyte mitochondrial ultrastructure was visualized by transmission electron microscopy and cytosolic and mitochondrial metabolic fluxes were determined by assessing NADH/FADH2 production from various substrates. Plasma GDF15 and FGF21 were determined by Luminex and acylcarnitines by LC-MS/MS. Gene expression was analyzed by RNA-sequencing and PCR-based glucose metabolism profiler array. RESULTS: Mitochondrial ultrastructure in patients with advanced cirrhosis was distinguished by cristae rarefication and swelling. The number of mitochondria per leukocyte was higher in patients, accompanied by a reduction in their size. Increased FGF21 and C6:0- and C8:0-carnitine predicted mortality whereas GDF15 strongly correlated with a gene set signature related to leukocyte activation. Metabolic flux analyses revealed increased energy production in mononuclear leukocytes from patients with preferential involvement of extra-mitochondrial pathways, supported by upregulated expression of genes encoding enzymes of the glycolytic and pentose phosphate pathways. In patients with ACLF, mitochondrial function analysis uncovered break-points in the TCA cycle at the isocitrate dehydrogenase and succinate dehydrogenase level, which were bridged by anaplerotic reactions involving glutaminolysis and nucleoside metabolism. CONCLUSIONS: Our findings provide evidence at the cellular, organelle and biochemical levels that severe mitochondrial dysfunction governs immunometabolism in leukocytes from patients with AD cirrhosis and ACLF. LAY SUMMARY: Patients at advanced stages of liver disease have dismal prognosis due to vital organ failures and the lack of treatment options. In this study, we report that the functioning of mitochondria, which are known as the cell powerhouse, is severely impaired in leukocytes of these patients, probably as a consequence of intense inflammation. Mitochondrial dysfunction is therefore a hallmark of advanced liver disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Zhang IW, Curto A, López-Vicario C, et al. Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure. J Hepatol. 2021. PMID: 34450236. doi:10.1016/j.jhep.2021.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。